According to our (Global Info Research) latest study, the global Nuclear Medical Device market size was valued at US$ 3499 million in 2025 and is forecast to a readjusted size of US$ 5379 million by 2032 with a CAGR of 6.4% during review period.
Nuclear Medical Device refers to advanced medical equipment that utilizes radionuclides, nuclear detection technologies, and related imaging and therapeutic systems for disease diagnosis, molecular imaging analysis, precision radiotherapy, and radionuclide therapy. Key products include Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), radiopharmaceutical injectors, gamma cameras, cyclotrons, and specialized therapeutic devices for nuclear medicine. These devices integrate cutting-edge achievements in medical imaging, molecular biology, and nuclear physics, playing an irreplaceable role in the early detection and personalized treatment of major diseases such as cancer, cardiovascular disorders, and neurological conditions. Nuclear medical devices not only reflect the growing demand for precision medicine and high-end imaging in healthcare systems but also represent a crucial direction for the deep integration of intelligent healthcare and life sciences.In 2024, global Nuclear Medical Device production reached approximately 1690 units, with an average global market price of around K US$ 1825.6 perunit.
With the acceleration of global population aging and the high prevalence of cancer, cardiovascular, and neurological diseases, the clinical applications of nuclear medical devices are expanding. Governments worldwide are increasing policy support and funding for advanced medical equipment, while healthcare providers are demanding higher accuracy in diagnostics and personalized therapy. At the same time, pharmaceutical companies and research institutes are advancing molecular imaging and radiopharmaceutical development, further enhancing the value of these devices and driving robust market growth.
The nuclear medical device industry requires substantial R&D investment and sophisticated manufacturing processes. High device costs, combined with complex installation and maintenance, remain key barriers for widespread adoption. The supply of radionuclides is dependent on upstream nuclear facilities and international policies, creating uncertainty. Additionally, strict regulations on radiation safety, quality certifications, and cross-border approvals increase compliance costs. Market competition is intensifying, with international leaders maintaining significant technological and distribution advantages over local players.
Future clinical demand will increasingly focus on early diagnosis and precision therapy. Nuclear medical devices will play a growing role in oncological molecular imaging, personalized radiotherapy, and systemic metabolic monitoring. Large tertiary hospitals will continue to dominate procurement, while regional medical centers and specialized hospitals are gradually increasing adoption. With the integration of AI and big data, nuclear medical devices are evolving from imaging acquisition tools into multimodal medical information platforms that meet clinical needs for real-time, intelligent, and visualized healthcare.
The core raw materials for nuclear medical devices include high-purity scintillation crystals for detectors, rare isotopes for accelerators and emission sources, and high-stability precision electronics and specialty metals. Scintillation crystals such as sodium iodide and cesium iodide directly affect imaging quality, but their production is complex and costly. Radionuclide supply depends heavily on a limited number of nuclear reactors and cyclotrons, making it closely tied to international cooperation. Meanwhile, the growing demand for advanced electronic components and radiation-resistant materials is fostering cross-industry collaboration with semiconductors and materials science.
This report is a detailed and comprehensive analysis for global Nuclear Medical Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Nuclear Medical Device market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Nuclear Medical Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Nuclear Medical Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Nuclear Medical Device market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nuclear Medical Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nuclear Medical Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Siemens Healthineers (Varian), Elekta, Accuray, Shanghai United Imaging, LinaTech, Neusoft, SHINVA Medical, China Isotope & Radiation, Huiheng Group, ET Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Nuclear Medical Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
External Beam Radiotherapy (EBRT) Equipment
Brachytherapy Equipment
Market segment by Clinical Indication
Oncology
Cardiology
Neurology
Other
Market segment by Radionuclide Type
Beta Emitters
Alpha Emitters
Gamma Emitters
Market segment by Application
Hospitals
Radiation Therapy Center
Major players covered
Siemens Healthineers (Varian)
Elekta
Accuray
Shanghai United Imaging
LinaTech
Neusoft
SHINVA Medical
China Isotope & Radiation
Huiheng Group
ET Medical
YingKang Life (MASEP)
OUR United Gorp
Best Theratronics
Ion Beam Applications
BEBIG Medical
Mevion Medical Systems
Best Cyclotron Systems
Advanced Cyclotron Systems
Sumitomo Heavy Industries
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Medical Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nuclear Medical Device, with price, sales quantity, revenue, and global market share of Nuclear Medical Device from 2021 to 2026.
Chapter 3, the Nuclear Medical Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medical Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Nuclear Medical Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nuclear Medical Device.
Chapter 14 and 15, to describe Nuclear Medical Device sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Nuclear Medical Device. Industry analysis & Market Report on Nuclear Medical Device is a syndicated market report, published as Global Nuclear Medical Device Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Nuclear Medical Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.